Cargando…
Helicobacter pylori Eradication Therapy, the Reasonable First Line Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Irrespective of Infection Status and Disease Stages
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Editorial Office of Gut and Liver
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003185/ https://www.ncbi.nlm.nih.gov/pubmed/27563015 http://dx.doi.org/10.5009/gnl16359 |
| _version_ | 1782450619697594368 |
|---|---|
| author | Cheung, Dae Young |
| author_facet | Cheung, Dae Young |
| author_sort | Cheung, Dae Young |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5003185 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Editorial Office of Gut and Liver |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-50031852016-09-09 Helicobacter pylori Eradication Therapy, the Reasonable First Line Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Irrespective of Infection Status and Disease Stages Cheung, Dae Young Gut Liver Editorial Editorial Office of Gut and Liver 2016-09 2016-09-15 /pmc/articles/PMC5003185/ /pubmed/27563015 http://dx.doi.org/10.5009/gnl16359 Text en Copyright © 2016 by The Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Neurogastroenterology and Motility, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association the Study of Intestinal Diseases, the Korean Association for the Study of the Liver, Korean Pancreatobiliary Association, and Korean Society of Gastrointestinal Cancer. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Cheung, Dae Young Helicobacter pylori Eradication Therapy, the Reasonable First Line Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Irrespective of Infection Status and Disease Stages |
| title | Helicobacter pylori Eradication Therapy, the Reasonable First Line Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Irrespective of Infection Status and Disease Stages |
| title_full | Helicobacter pylori Eradication Therapy, the Reasonable First Line Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Irrespective of Infection Status and Disease Stages |
| title_fullStr | Helicobacter pylori Eradication Therapy, the Reasonable First Line Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Irrespective of Infection Status and Disease Stages |
| title_full_unstemmed | Helicobacter pylori Eradication Therapy, the Reasonable First Line Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Irrespective of Infection Status and Disease Stages |
| title_short | Helicobacter pylori Eradication Therapy, the Reasonable First Line Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Irrespective of Infection Status and Disease Stages |
| title_sort | helicobacter pylori eradication therapy, the reasonable first line therapy for gastric mucosa-associated lymphoid tissue lymphoma irrespective of infection status and disease stages |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003185/ https://www.ncbi.nlm.nih.gov/pubmed/27563015 http://dx.doi.org/10.5009/gnl16359 |
| work_keys_str_mv | AT cheungdaeyoung helicobacterpylorieradicationtherapythereasonablefirstlinetherapyforgastricmucosaassociatedlymphoidtissuelymphomairrespectiveofinfectionstatusanddiseasestages |